OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study

Liam G Heaney; Andrew Menzies-Gow; Mark Gurnell; Jonathan  Corren; Elisabeth H Bel; Jorge F Maspero; Timothy  Harrison; David Jackson; David Price; Njira Lugogo; James  Kreindler; Annie Burden; Alex  de Giorgio-Miller; Kelly  Padilla; Ubaldo J.  Martin; Esther Garcia Gil

OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study

Liam G Heaney, Andrew Menzies-Gow, Mark Gurnell, Jonathan Corren, Elisabeth H Bel, Jorge F Maspero, Timothy Harrison, David Jackson, David Price, Njira Lugogo, James Kreindler, Annie Burden, Alex de Giorgio-Miller, Kelly Padilla, Ubaldo J. Martin, Esther Garcia Gil

Research output: Contribution to conference › Abstract › peer-review

Abstract

Severe asthma is frequently associated with comorbidities. Nasal polyps (NP), in particular, indicate an eosinophilic phenotype and have been shown to predict an enhanced response to benralizumab in terms of asthma exacerbations and lung function. I

Original language	English
Publication status	Accepted/In press - 12 Mar 2021
Event	ATS International Conference Committee: ATS 2021 - Virtual event Duration: 14 May 2021 → 19 May 2021 https://conference.thoracic.org/

Conference

Conference	ATS International Conference Committee
Period	14/05/21 → 19/05/21
Internet address	https://conference.thoracic.org/

Access to Document

Heany_et_al_ATS21_OCSReductionAccording_AAM
Originally Published in: [Authors]. [Article Title]. [Journal Name] [Year];[Volume]:[Pages]. DOI: [Number] Copyright © 2021 by the American Thoracic Society The final publication is available at [Link].
Accepted author manuscript, 161 KBLicence: Other

Fingerprint Dive into the research topics of 'OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study'. Together they form a unique fingerprint.

Cite this

Heaney, L. G., Menzies-Gow, A., Gurnell, M., Corren, J., Bel, E. H., Maspero, J. F., Harrison, T., Jackson, D., Price, D., Lugogo, N., Kreindler, J., Burden, A., de Giorgio-Miller, A., Padilla, K., Martin, U. J., & Gil, E. G. (Accepted/In press). OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study. Abstract from ATS International Conference Committee, .

OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study. / Heaney, Liam G; Menzies-Gow, Andrew; Gurnell, Mark; Corren, Jonathan ; Bel, Elisabeth H; Maspero, Jorge F; Harrison, Timothy ; Jackson, David; Price, David; Lugogo, Njira; Kreindler, James ; Burden, Annie; de Giorgio-Miller, Alex ; Padilla, Kelly ; Martin, Ubaldo J. ; Gil, Esther Garcia.

2021. Abstract from ATS International Conference Committee, .

Research output: Contribution to conference › Abstract › peer-review

Heaney, Liam G ; Menzies-Gow, Andrew ; Gurnell, Mark ; Corren, Jonathan ; Bel, Elisabeth H ; Maspero, Jorge F ; Harrison, Timothy ; Jackson, David ; Price, David ; Lugogo, Njira ; Kreindler, James ; Burden, Annie ; de Giorgio-Miller, Alex ; Padilla, Kelly ; Martin, Ubaldo J. ; Gil, Esther Garcia. / OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study. Abstract from ATS International Conference Committee, .

@conference{76fad59ed92c4d88b26d54c7eadfc697,

title = "OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study",

abstract = " Severe asthma is frequently associated with comorbidities. Nasal polyps (NP), in particular, indicate an eosinophilic phenotype and have been shown to predict an enhanced response to benralizumab in terms of asthma exacerbations and lung function. I",

author = "Heaney, {Liam G} and Andrew Menzies-Gow and Mark Gurnell and Jonathan Corren and Bel, {Elisabeth H} and Maspero, {Jorge F} and Timothy Harrison and David Jackson and David Price and Njira Lugogo and James Kreindler and Annie Burden and {de Giorgio-Miller}, Alex and Kelly Padilla and Martin, {Ubaldo J.} and Gil, {Esther Garcia}",

year = "2021",

month = mar,

day = "12",

language = "English",

note = "ATS International Conference Committee : ATS 2021 ; Conference date: 14-05-2021 Through 19-05-2021",

url = "https://conference.thoracic.org/",

}

TY - CONF

T1 - OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study

AU - Heaney, Liam G

AU - Menzies-Gow, Andrew

AU - Gurnell, Mark

AU - Corren, Jonathan

AU - Bel, Elisabeth H

AU - Maspero, Jorge F

AU - Harrison, Timothy

AU - Jackson, David

AU - Price, David

AU - Lugogo, Njira

AU - Kreindler, James

AU - Burden, Annie

AU - de Giorgio-Miller, Alex

AU - Padilla, Kelly

AU - Martin, Ubaldo J.

AU - Gil, Esther Garcia

PY - 2021/3/12

Y1 - 2021/3/12

N2 - Severe asthma is frequently associated with comorbidities. Nasal polyps (NP), in particular, indicate an eosinophilic phenotype and have been shown to predict an enhanced response to benralizumab in terms of asthma exacerbations and lung function. I

AB - Severe asthma is frequently associated with comorbidities. Nasal polyps (NP), in particular, indicate an eosinophilic phenotype and have been shown to predict an enhanced response to benralizumab in terms of asthma exacerbations and lung function. I

M3 - Abstract

T2 - ATS International Conference Committee

Y2 - 14 May 2021 through 19 May 2021

ER -